L
Lewis L. Lanier
Researcher at University of California, San Francisco
Publications - 576
Citations - 93495
Lewis L. Lanier is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Interleukin 21 & Natural killer cell. The author has an hindex of 159, co-authored 554 publications receiving 86677 citations. Previous affiliations of Lewis L. Lanier include University of Rome Tor Vergata & Cancer Research Institute.
Papers
More filters
Journal ArticleDOI
Natural Killer (NK) Cells Respond to CMV Reactivation After Allogeneic Transplantation with An Increase in NKG2C+CD57+ Self-KIR+ NK Cells with Potent IFNγ Production
Bree Foley,Michael R. Verneris,Julie M. Curtsinger,Sandra López-Vergès,Lewis L. Lanier,Daniel J. Weisdorf,Sarah Cooley,Jeffrey S. Miller +7 more
TL;DR: NK cell function after hCMV reactivation was studied and it was found that the maximum IFNγ production occurred at 4 weeks, with the peak NKG2C+ NK cells with increased cytokine production at 8 weeks post infection.
Book ChapterDOI
A Schema for the Classification of Cytotoxic Lymphocytes Based on T Cell Antigen Receptor Gene Rearrangement and Fc Receptor (CD 16) or NKH-1/Leu 19 Antigen Expression
Journal ArticleDOI
Founding father of FACS: Professor Leonard A. Herzenberg (1931–2013)
TL;DR: FACS applied in conjunction with fluorescently labeled monoclonal antibodies derived from immortalized hybridoma cell lines is a ubiquitous core technology in medicine and biomedical research, impacting all of immunology, cancer diagnosis, stem cell identification and transplantation, AIDS monitoring, and a variety of therapies, as well as plant and microbial biology.
Journal ArticleDOI
First Sighting of the Elusive T Cell Antigen Receptor
TL;DR: The TCR—the molecule in the T cell membrane capable of specifically binding Ags—is the San Andreas Fault of immunology: here the plates rub against each other and a major ‘ fault’ occurs.
Journal ArticleDOI
Lym 7.3: New murine specificity defining third allele of the ly 7 locus.
Lewis L. Lanier,Noel L. Warner +1 more
TL;DR: A new antigenic specificity, designated Lym 7.3, defines a third allele of the Ly 7 locus that was produced by a hybridoma derived from immunization of B10.D2 Ign mice against a (BALB/c X NZB) F1 murine B lymphoma cell line (WEHI-5).